NCT07098364 2026-01-14ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell LymphomaFred Hutchinson Cancer CenterPhase 1/2 Recruiting33 enrolled
NCT05359211 2025-09-15NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell LymphomaFred Hutchinson Cancer CenterPhase 1 Active not recruiting28 enrolled